Xeris Biopharma Holdings, Inc. Share Price
XERSXeris Biopharma Holdings, Inc. Stock Performance
Open $6.42 | Prev. Close $6.25 | Circuit Range N/A |
Day Range $6.35 - $6.54 | Year Range $4.30 - $10.07 | Volume 84,314 |
Average Traded $6.46 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $6.42 | $6.49 | +0.00% |
09-Jun-26 | $6.42 | $6.49 | +3.84% |
08-Jun-26 | $6.23 | $6.25 | +1.21% |
05-Jun-26 | $6.22 | $6.17 | +0.49% |
04-Jun-26 | $5.98 | $6.14 | +4.33% |
03-Jun-26 | $5.94 | $5.89 | -1.75% |
02-Jun-26 | $5.96 | $6.00 | -1.07% |